Market Cap (In USD)
409.14 Million
Revenue (In USD)
139.91 Million
Net Income (In USD)
68.06 Million
Avg. Volume
1.43 Million
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 4.26-12.83
- PE
- -
- EPS
- -
- Beta Value
- 0.886
- ISIN
- US8269171067
- CUSIP
- 826917106
- CIK
- 1010086
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Dr. Diem Nguyen M.B.A., Ph.D.
- Employee Count
- -
- Website
- https://www.siga.com
- Ipo Date
- 1997-09-10
- Details
- SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
More Stocks
-
THRThor Energy Plc
THR
-
RELL
-
EVZEVZ Limited
EVZ
-
ICLR
-
CR1
-
LUMAXTECHLumax Auto Technologies Limited
LUMAXTECH
-
OPLOpyl Limited
OPL
-
MITTALMittal Life Style Limited
MITTAL